Targeted protein degradation mechanisms
The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Targeted protein degradation mediated by small molecule degraders represents an exciting new therapeutic opportunity to eliminate disease-causing proteins. These molecules recruit E3 ubiquitin ligases to the protein of interest and mediate its ubiquitination and subsequent proteolysis by the proteasome. Significant advancements have been made in the discovery and development of clinically relevant degraders. In this review we will focus on the recent progress in understanding ternary complex formation and structures, ubiquitination, and other critical factors that govern the efficiency of degraders both in vitro and in vivo. With deeper knowledges of these areas, the field is building guiding principles to reduce the level of empiricism and to identify therapeutically relevant degraders more rationally and efficiently.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
Phthalimide conjugation as a strategy for in vivo target protein degradation
Winter, G. E., Buckley, D. L., Paulk, J., Roberts, J. M., Souza, A., Dhe-Paganon, S., & Bradner, J. E. (2015) · Science · doi:10.1126/science.aab1433 · Cited by 1,760
Catalytic in vivo protein knockdown by small-molecule PROTACs
Bondeson, D. P., Mares, A., Smith, I. E. D., Ko, E., Campos, S., Miah, A. H., Mulholland, K. E., Routly, N., Buckley, D. L., Gustafson, J. L., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1858 · Cited by 1,356
Structural basis of PROTAC cooperative recognition for selective protein degradation
Gadd, M. S., Testa, A., Lucas, X., Chan, K.-H., Chen, W., Lamont, D. J., Zengerle, M., & Ciulli, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2329 · Cited by 1,242
The dTAG system for immediate and target-specific protein degradation
Nabet, B., Roberts, J. M., Buckley, D. L., Paulk, J., Dastjerdi, S., Yang, A., Leggett, A. L., Erb, M. A., Lawlor, M. A., Souza, A., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0021-8 · Cited by 1,118
Plasticity in binding confers selectivity in ligand-induced protein degradation
Nowak, R. P., DeAngelo, S. L., Buckley, D., He, Z., Donovan, K. A., An, J., Safaee, N., Jedrychowski, M. P., Ponthier, C. M., Ishoey, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0055-y · Cited by 615
Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
Churcher, I. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01272 · Cited by 491
A Comprehensive Mathematical Model for Three-Body Binding Equilibria
Douglass, E. F., Miller, C. J., Sparer, G., Shapiro, H., & Spiegel, D. A. (2013) · Journal of the American Chemical Society · doi:10.1021/ja311795d · Cited by 472
Winter, G. E., Mayer, A., Buckley, D. L., Erb, M. A., Roderick, J. E., Vittori, S., Reyes, J. M., di Iulio, J., Souza, A., Ott, C. J., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.06.004 · Cited by 465
Delineating the role of cooperativity in the design of potent PROTACs for BTK
Zorba, A., Nguyen, C., Xu, Y., Starr, J., Borzilleri, K., Smith, J., Zhu, H., Farley, K. A., Ding, W., Schiemer, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803662115 · Cited by 419
Self-citationSPR-measured dissociation kinetics of PROTAC ternary complexes influence target degradation rate
Roy, M. J., Winkler, S., Hughes, S. J., Whitworth, C., Galant, M., Farnaby, W., Rumpel, K., & Ciulli, A. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.9b00092 · Cited by 386
Lu, M., Liu, T., Jiao, Q., Ji, J., Tao, M., Liu, Y., You, Q., & Jiang, Z. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.063 · Cited by 310
Qin, C., Hu, Y., Zhou, B., Fernandez-Salas, E., Yang, C.-Y., Liu, L., McEachern, D., Przybranowski, S., Wang, M., Stuckey, J., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00506 · Cited by 281
Maniaci, C., Hughes, S. J., Testa, A., Chen, W., Lamont, D. J., Rocha, S., Alessi, D. R., Romeo, R., & Ciulli, A. (2017) · Nature Communications · doi:10.1038/s41467-017-00954-1 · Cited by 245
Hughes, S. J., & Ciulli, A. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170041 · Cited by 240
Functional TRIM24 degrader via conjugation of ineffectual bromodomain and VHL ligands
Gechijian, L. N., Buckley, D. L., Lawlor, M. A., Reyes, J. M., Paulk, J., Ott, C. J., Winter, G. E., Erb, M. A., Scott, T. G., Xu, M., et al. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0010-y · Cited by 222
Assessing Different E3 Ligases for Small Molecule Induced Protein Ubiquitination and Degradation
Ottis, P., Toure, M., Cromm, P. M., Ko, E., Gustafson, J. L., & Crews, C. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00485 · Cited by 176
Targeted protein degradation and the enzymology of degraders
Fisher, S. L., & Phillips, A. J. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.05.004 · Cited by 126
Research works printed but not linked: 20
- Steinebach, 2018, Homo-PROTACs for the chemical knockdown of cereblon, ACS Chem Biol, 13, 2771, 10.1021/acschembio.8b00693 · DOI · Paper page
- Mainolfi, 2017, Targeted protein degradation, Annu Rep Med Chem, 50, 301
- Tinworth, 2016, Small molecule-mediated protein knockdown as a new approach to drug discovery, Medchemcomm, 7, 2206, 10.1039/C6MD00347H · DOI · Paper page
- Cromm, 2017, Targeted protein degradation: from chemical biology to drug discovery, Cell Chem Biol, 24, 1181, 10.1016/j.chembiol.2017.05.024 · DOI · Paper page
- Riching, 2018, Quantitative live-cell kinetic degradation and mechanistic profiling of PROTAC mode of action, ACS Chem Biol, 13, 2758, 10.1021/acschembio.8b00692 · DOI · Paper page
- Chan, 2018, Impact of target warhead and linkage vector on inducing protein degradation: comparison of bromodomain and extra-terminal (BET) degraders derived from triazolodiazepine (JQ1) and tetrahydroquinoline (I-BET726) BET inhibitor scaffolds, J Med Chem, 61, 504, 10.1021/acs.jmedchem.6b01912 · DOI · Paper page
- Collins, 2017, Chemical approaches to targeted protein degradation through modulation of the ubiquitin–proteasome pathway, Biochem J, 474, 1127, 10.1042/BCJ20160762 · DOI · Paper page
- Remillard, 2017, Degradation of the BAF complex factor BRD9 by heterobifunctional ligands, Angew Chem Int Ed Engl, 56, 5738, 10.1002/anie.201611281 · DOI · Paper page
- Schiedel, 2018, Chemically induced degradation of sirtuin 2 (Sirt2) by a proteolysis targeting chimera (PROTAC) based on sirtuin rearranging ligands (SirReals), J Med Chem, 61, 482, 10.1021/acs.jmedchem.6b01872 · DOI · Paper page
- Cesare, 2018, The MALDI-TOF E2/E3 ligase assay as universal tool for drug discovery in the ubiquitin pathway, Cell Chem Biol, 20, 1117, 10.1016/j.chembiol.2018.06.004 · DOI
- Kirkpatrick, 2005, The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications, Methods, 35, 265, 10.1016/j.ymeth.2004.08.018 · DOI · Paper page
- Grice, 2016, The recognition of ubiquitinated proteins by the proteasome, Cell Mol Life Sci, 73, 3497, 10.1007/s00018-016-2255-5 · DOI · Paper page
- Bustos, 2012, Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment, Mol Cell Proteomics, 11, 1529, 10.1074/mcp.R112.019117 · DOI
- McDowell, 2013, Non-canonical ubiquitylation: mechanisms and consequences, J Int Biochem Cell Biol, 45, 1833, 10.1016/j.biocel.2013.05.026 · DOI · Paper page
- Xu, 2010, Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling, Nat Biotechnol, 28, 868, 10.1038/nbt.1654 · DOI · Paper page
- Akutsu, 2016, Ubiquitin chain diversity at a glance, J Cell Sci, 129, 875, 10.1242/jcs.183954 · DOI · Paper page
- Harris, 2015, Protein detection by Simple Western™ analysis, Methods Mol Biol, 1312, 465, 10.1007/978-1-4939-2694-7_47 · DOI
- Schulze, 2014, Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4, J Biomol Screen, 20, 180, 10.1177/1087057114552398 · DOI
- Savitski, 2018, Multiplexed proteome dynamics profiling reveals mechanisms controlling protein homeostasis, Cell, 173, 260, 10.1016/j.cell.2018.02.030 · DOI · Paper page
- Zhang, 2017, Relative protein quantification using tandem mass tag mass spectrometry, Proteomics, 1550, 185, 10.1007/978-1-4939-6747-6_14 · DOI
Cited by
Current strategies for the design of PROTAC linkers: a critical review
Troup, R. I., Fallan, C., & Baud, M. G. J. (2020) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2020.00018 · Cited by 424
“These new contacts suggested that isoform-specific interactions could increase the cooperativity (α) of the TC and provide a blueprint towards generalisable approaches aimed at improving the potency and selectivity of PROTACs by exploiting TC specific interactions [135-137].”
BackgroundImpact of Cross-Coupling Reactions in Drug Discovery and Development
Buskes, M. J., & Blanco, M.-J. (2020) · Molecules · doi:10.3390/molecules25153493 · Cited by 296
Recent Developments in PROTAC‐Mediated Protein Degradation: From Bench to Clinic
Hu, Z., & Crews, C. M. (2022) · ChemBioChem · doi:10.1002/cbic.202100270 · Cited by 231
Drummond, M. L., Henry, A., Li, H., & Williams, C. I. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00897 · Cited by 166
Bifunctional chemical probes inducing protein–protein interactions
Maniaci, C., & Ciulli, A. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.07.003 · Cited by 100
Metadata
- Authors
- Zhang, Y., Loh, C., Chen, J., & Mainolfi, N.
- Venue
- Drug Discovery Today: Technologies
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 31
- Pages
- 53-60
- ISSN
- 1740-6749 (ISSN-L)
- OpenAlex
- W2911917285
- Cited by
- 45
- References
- 19
- FWCI
- 2.22
- Type
- journal article
- Language
- en
- Update notices
- erratum (2020-12-01)
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.